-
‘Don’t give up’: Long-term lebrikizumab for AD may benefit initial nonresponders
29 Jan 2025 21:15 GMT
January 29, 2025
2 min read
Add topic to email alerts
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Of the 147 lebrikizumab-treated …
-
US close: Nasdaq breaks above 20,000 on AI optimism
23 Jan 2025 02:04 GMT
… and Mexico.
The tech-heavy Nasdaq led the charge on Wednesday … ) $95.68 -0.58%
Amgen Inc. (AMGN) $273.44 -0.50%
International … . (XRAY) $19.36 2.11%
Nasdaq 100 - Fallers
Expedia Group … -2.09%
Vodafone Group Plc ADS (VOD) $8.38 -1.99% …
-
US close: Stocks erase losses after late rally, Nasdaq stays lower
14 Jan 2025 03:09 GMT
… .9% earlier on, while the Nasdaq fell 0.4%.
The Dow … (AAP) $44.85 -2.92%
Nasdaq 100 - Risers
Illumina Inc …
NetEase Inc. Ads (NTES) $94.25 3.45%
Amgen Inc. (AMGN) $270.19 …
Vodafone Group Plc ADS (VOD) $8.20 1.86%
Nasdaq 100 - …
-
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
29 Jan 2025 18:00 GMT
New York, USA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight The BRAF Inhibitors market is expected to grow significantly in the coming years. This is due to the …
-
WomenHeart and HealthyWomen Announce 2025 Heart Health IS Women’s Health Summit, Wenger Awards, and Advocacy Day
28 Jan 2025 17:28 GMT
WomenHeart announces the 2025 Heart Health IS Women’s Health Summit, Wenger Awards, and Advocacy Day to spotlight and advance women’s heart health.
WASHINGTON, DC, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE …
-
Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions
28 Jan 2025 11:00 GMT
HCR-188, a clinic-ready antibody, entering first-in-human clinical studies with top-line data anticipated in the second half of 2025 Building on existing validation of GIP pathway antagonism with differentiated antibody format and a novel focus on binding …
-
Shane Lowry confirmed for 2025 Amgen Irish Open at The K Club
11 Dec 2024 13:47 GMT
… on sale here for the Amgen Irish Open’s return … excited for next year’s Amgen Irish Open,” said the … by three strokes.
The Amgen Irish Open once again assumes … CONTINUE READING BELOW
ADVERTISEMENT - CONTINUE READING BELOW
ADVERTISEMENT - CONTINUE READING …
-
What you need to know about thyroid conditions- sponsored by Amgen
06 Dec 2024 18:53 GMT
Learn More about Living with Thyroid Conditions and the Heightened Risk of Thyroid Eye Disease
CHARLOTTE, N.C. — This article involves commercial content.
The products and services featured appear as paid advertising.
Today in our health spotlight, World- …
-
US close: Stocks rangebound but S&P 500, Nasdaq hit fresh highs
04 Dec 2024 01:01 GMT
… to South Korea fell, including ADS shares of Korea Electric Power … ) $331.43 0.13%
Amgen Inc. (AMGN) $278.45 0.13%
Goldman … (NCLH) $27.38 -3.42%
Nasdaq 100 - Risers
Trip.com … . (CDNS) $313.42 1.02%
Nasdaq 100 - Fallers
Microchip Technology …
-
US close: Dow falls for fourth day, but Nvidia lifts Nasdaq
19 Nov 2024 22:45 GMT
… providing a lift on the Nasdaq, jumping nearly 5% ahead of … ) $417.79 0.49%
Amgen Inc. (AMGN) $279.95 0.43%
Salesforce … . (CDNS) $299.70 1.83%
Nasdaq 100 - Fallers
Qurate Retail … .05 -2.96%
NetEase Inc. Ads (NTES) $85.69 -2.91% …